ASBP - Aspire BioPharma, Inc.
Aspire BioPharma, Inc. Logo

ASBP - Aspire BioPharma, Inc.

https://aspirebiolabs.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.

52W High
$15.80
52W Low
$0.22

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.91
Valuation
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
N/A
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
33.08%
Institutions (25–75% balanced)
2.90%
Shares Outstanding
49,526,000
Float
34,700,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2025-03-31 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-0.58
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.0044
Previous
0.0126
Trend
Falling
Signal Cross
No cross

As of
Sep. 12, 2025